SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed after announcing a capital raise through a public stock offering and a non-dilutive royalty funding agreement, leading to community debate over the potential dilution versus the strategic financial runway now secured for advancing their prostate cancer drug towards anticipated regulatory submission and other pipeline assets.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following Q4 earnings that showcased robust IBSRELA revenue growth and positive cash flow, with increased operating expenses reflecting strategic investments in future pipeline and sales expansion. This, combined with extended patent protection for tenapanor until 2042 and multiple analyst price target raises, fuels community discussions about its significant undervaluation and potential as a long-term growth or acquisition target.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is currently trending as its community rallies around the approaching 4/20 event, underscoring a "culture first" ethos and long-term vision, while also tapping into wider conversations about cannabis rescheduling and the plant's emerging medicinal potential.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is trending due to a significant selloff following its NHS-Galleri cancer screening trial missing a primary endpoint for statistically significant reduction in late-stage cancer diagnoses, leading to analyst price target cuts. The community is divided, with bears pressing shorts on the perceived failure and cash burn, while bulls view the sharp decline as an overreaction, highlighting strong cash reserves, U.S. sales, and the test's continued potential for early detection.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space (FJET) is experiencing robust momentum and community chatter as it prepares to ring the NYSE Opening Bell, with investors speculating on a potential short squeeze due to its low float and a broader surge of interest in the space and defense sector, amplified by recent hypersonic technology news.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as the market grapples with weaker-than-expected GDP and hotter inflation data, prompting community discussion around potential stagflation while some paradoxically anticipate rate cuts. Heightened geopolitical tensions regarding Iran and an awaited Supreme Court ruling on tariffs further contribute to the mixed sentiment and speculative trading.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending as its community actively discusses the long-term potential of this 'move-to-earn' crypto, which rewards physical activity, with many expressing hopes for a significant future rebound despite its current low valuation.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as positive comments from PepsiCo's recent earnings and a strong management update at the CAGNY conference, coupled with analyst upgrades, fuel bullish sentiment around its market share gains and future growth. However, community discussion is intensely divided, with some attributing recent stock weakness to alleged management incompetence and deliberate manipulation to facilitate a low-cost acquisition by Pepsi.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto ($RAGE) is trending due to its highly active community's unwavering conviction in its 'OG meme' status, with members relentlessly building and promoting its deep roots from the early 2000s as they aim for a significant valuation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble (RUM) is trending due to its pending acquisition of Northern Data, which aims to boost its cloud capacity for government and AI, and significant investment pledges from Tether. Community sentiment is largely focused on a potential short squeeze driven by high short interest, though many also voice skepticism regarding sustained price performance amidst new initiatives like Rumble Shorts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRVO We’re thrilled that neflamapimod has been selected by the UK’s EXPERTS-ALS platform to assess its potential as an ALS treatment.
 
Funded by the UK government and leading motor neuron disease charities, EXPERTS-ALS conducts an ongoing clinical trial at sites throughout the UK to rapidly identify promising drug candidates and expedite their development.
 
Neflamapimod was selected based on its mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging translational data in relevant neurotoxicity models. This will be the first clinical study to evaluate neflamapimod in ALS.
 
ALS is a devastating disease for people with the condition and their families, and we’re proud to partner with EXPERTS-ALS.
 
You can read more here: https://lnkd.in/e455yvzN
 
#ALS #neflamapimod

Michael V

This link will take you to a page that's not on LinkedIn

Lnkd

LinkedIn

StockTwits for iOS

CervoMed Inc

 We’re thrilled that neflamapimod has been selected by the UK’s EXPERTS-ALS platform to assess its potential as an ALS treatment.
 
Funded by the UK government and leading motor neuron disease charities, EXPERTS-ALS conducts an ongoing clinical trial at sites throughout the UK to rapidly identify promising drug candidates and expedite their development.
 
Neflamapimod was selected based on its mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging translational data in relevant neurotoxicity models. This will be the first clinical study to evaluate neflamapimod in ALS.
 
ALS is a devastating disease for people with the condition and their families, and we’re proud to partner with EXPERTS-ALS.
 
You can read more here: 